The QPS Qualitix China Office will provide various knowledge-based contract research services including comprehensive clinical trial management and regulatory submission preparation
The facility will also allow the company to develop customized offerings in key therapeutic areas, along with phase II-IV studies, biostatistics, data management, medical writing, vaccines, medical devices and diagnostics.
QPS Qualitix China general manager Vincent Yen said the new facility will leverage the company’s quality and training systems to offer customized drug development solutions which suites local Chinese biopharma, as well as global biopharma’s local affiliates.
"We have an aggressive growth plan for China and anticipate increasing QPS’ total staff there during 2012 as we look to provide our customers with the solutions they need to succeed in one of the world’s most dynamic marketplaces," Yen added.